Traditional Medicine of Baja California Sur (Mexico). IDIMAYUGA, R. E; AGUNDEZ, J.Journal of ethnopharmacology. 1986, Vol 17, Num 2, pp 183-193, issn 0378-8741Article

Evidence of zeolitic-like domains in mesostructured aluminosilicates : FTIR spectroscopy of basic probe moleculesSANEHEZ, M. T; AGUNDEZ, J; PEREZ-PARIENTE, J et al.Studies in surface science and catalysis. 2007, pp 1905-1911, issn 0167-2991, isbn 978-0-444-53068-4, 2Vol, 7 p.Conference Paper

Caffeine demethylase activity in human and dark agouti rat liver microsomes : comparison with aminopyrine N-demethylase activityAGUNDEZ, J. A. G; LUENGO, A; BENITEZ, J et al.Drug metabolism and disposition. 1992, Vol 20, Num 3, pp 343-349, issn 0090-9556Article

Determination of aminopyrine and dipyrone metabolites in urineAGUNDEZ, J. A. G; BENITEZ, J.Therapeutic drug monitoring. 1996, Vol 18, Num 1, pp 104-107, issn 0163-4356Article

Determination of aminopyrine, dipyrone and its metabolites in urine by high-performance liquid chromatographyAGUNDEZ, J. A. G; MARTINEZ, C; MARTIN, R et al.Therapeutic drug monitoring. 1994, Vol 16, Num 3, pp 316-322, issn 0163-4356Article

Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography : Probe of CYP3ACARRILLO, J. A; RAMOS, S. I; AGUNDEZ, J. A. G et al.Therapeutic drug monitoring. 1998, Vol 20, Num 3, pp 319-324, issn 0163-4356Article

Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white populationAGUNDEZ, J. A. G; OLIVERA, M; MARTINEZ, C et al.Pharmacogenetics (London). 1996, Vol 6, Num 5, pp 423-428, issn 0960-314XArticle

Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenalineGERVASINI, G; MARTINEZ, C; AGUNDEZ, J. A. G et al.Pharmacogenetics (London). 2001, Vol 11, Num 1, pp 29-37, issn 0960-314XArticle

Modulation of CYP1A2 enzyme activity by indoleamines : inhibition by serotonin and tryptamineAGUNDEZ, J. A. G; GALLARDO, L; MARTINEZ, C et al.Pharmacogenetics (London). 1998, Vol 8, Num 3, pp 251-258, issn 0960-314XArticle

Molecular heterogeneity at the CYP2D gene locus in Nicaraguans : impact of gene-flow from EuropeAGUNDEZ, J. A. G; RAMIREZ, R; HERNANDEZ, M et al.Pharmacogenetics (London). 1997, Vol 7, Num 4, pp 337-340, issn 0960-314XArticle

Tryptamine : a possible endogenous substrate for CYP2D6MARTINEZ, C; AGUNDEZ, J. A. G; GERVASINI, G et al.Pharmacogenetics (London). 1997, Vol 7, Num 2, pp 85-93, issn 0960-314XArticle

Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white populationAGUNDEZ, J. A. G; LEDESMA, M. C; LADERO, J. M et al.Clinical pharmacology and therapeutics. 1995, Vol 57, Num 3, pp 265-269, issn 0009-9236Article

Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes : Analyses of mutations on NAT2 and CYP2E1 genes in a mixed Hispanic populationMARTINEZ, C; AGUNDEZ, J. A. G; OLIVERA, M et al.Clinical pharmacology and therapeutics. 1998, Vol 63, Num 6, pp 623-628, issn 0009-9236Article

Genetic basic for differences in debrisoquin polymorphism between a Spanish and other white populationsAGUNDEZ, J. A. G; MARTINEZ, C; LEDESMA, M. C et al.Clinical pharmacology and therapeutics. 1994, Vol 55, Num 4, pp 412-417, issn 0009-9236Article

Dinucleotide tetraphosphatase from human blood cells : purification and characterization as a high specific activity enzyme recognized by an anti-rat tetraphosphatase antibodyPINTO, R. M; COSTAS, M. J; FERNANDEZ, A et al.FEBS letters. 1991, Vol 287, Num 1-2, pp 85-88, issn 0014-5793Article

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H₂-receptor antagonistsMARTINEZ, C; ALBET, C; AGUNDEZ, J. A. G et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 4, pp 369-376, issn 0009-9236Article

Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapyMARTINEZ, C; GARCIA-MARTIN, E; PIZARRO, R. M et al.British journal of cancer. 2002, Vol 87, Num 6, pp 681-686, issn 0007-0920Article

Possible implications of doxycycline-rifampin interaction for treatment of brucellosisCOLMENERO, J. D; FERNANDEZ-GALLARDO, L. C; AGUNDEZ, J. A. G et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 12, pp 2798-2802, issn 0066-4804Article

N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in CaucasiansLEIRO-FERNANDEZ, V; VALVERDE, D; VAZQUEZ-GALLARDO, R et al.The International journal of tuberculosis and lung disease. 2011, Vol 15, Num 10, pp 1403-1408, issn 1027-3719, 6 p.Article

Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitisGARCIA-MARTIN, E; GARCIA-MENAYA, J; SANCHEZ, B et al.Clinical and experimental allergy (Print). 2007, Vol 37, Num 8, pp 1175-1182, issn 0954-7894, 8 p.Article

RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinomaLADERO, J. M; AGUNDEZ, J. A. G; RODRIGUEZ-LESCURE, A et al.Gut. 1996, Vol 39, Num 2, pp 330-333, issn 0017-5749Article

Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitusAGUNDEZ, J. A. G; MENAYA, J. G; TEJEDA, R et al.Pharmacogenetics (London). 1996, Vol 6, Num 5, pp 465-472, issn 0960-314XArticle

Particulate diadenosine 5',5'''-P¹,P³-triphosphate hydrolases in rat brain : two specific dinucleoside triphosphatases and two phosphodiesterase I-like hydrolasesGARCIA-AGUNDEZ, J. A; CAMESELLE, J. C; COSTAS, M. J et al.Biochimica et biophysica acta (G). General subjects. 1991, Vol 1073, Num 2, pp 402-409, issn 0304-4165, 8 p.Article

N-Acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver diseaseAGUNDEZ, J. A. G; LADERO, J. M; OLIVERA, M et al.Scandinavian journal of gastroenterology. 2002, Vol 37, Num 1, pp 99-103, issn 0036-5521Article

Expression in human prostate of drug- and carcinogen-metabolizing enzymes : association with prostate cancer riskAGUNDEZ, J. A. G; MARTINEZ, C; OLIVERA, M et al.British journal of cancer. 1998, Vol 78, Num 10, pp 1361-1367, issn 0007-0920Article